Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.
about
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BEstimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxisPsychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients.Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.Linking medicine and economics: health economics and quality of life in haemophilia care.Adverse events in the prophylaxis of haemophilia.Health-related quality of life as outcome parameter in haemophilia treatment.Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments.Quality of life assessment in haemophilia.Disease-specific quality-of-life measurement tools for haemophilia patients.Preventing perioperative bleeding in patients with inherited bleeding disorders.A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A managementProphylaxis in haemophilia patients with inhibitors.Haemophilia therapies.Barriers and perceived limitations to early treatment of hemophilia.Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers.Haemophilia A: meeting the needs of individual patients.Physiotherapy treatment in patients with hemophilia and chronic ankle arthropathy: a systematic reviewAntihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia AThe history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.Joint protection in haemophilia.Tertiary prophylaxis in adults: is there a rationale?Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia.A review of evidence about behavioural and psychological aspects of chronic joint pain among people with haemophilia.The role of Rixubis™ in the treatment of hemophilia B.Outcome measures in haemophilia: a systematic review.On-demand treatment in persons with severe haemophilia.The growing number of hemophilia registries: Quantity vs. quality.Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II).Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials.Effect of late prophylaxis in hemophilia on joint status: a randomized trial.Social/economic costs and quality of life in patients with haemophilia in Europe.Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.Bone density and health-related quality of life in adult patients with severe haemophilia.Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.Young adults with hemophilia in the U.S.: demographics, comorbidities, and health status.The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study.Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.
P2860
Q24234413-DFC91332-9A2B-4212-B0F4-2B55DC06958EQ26865814-10CC7F65-99D2-43D2-87C3-2B7700443F0AQ33634745-E15479E1-4ABB-4186-AC2C-B080D3DEEB85Q33937275-917DF844-D022-4B93-B418-FC01C57993D8Q34522059-F91E956F-AADA-4E8D-A355-D8D92674FFD4Q34636921-A728F371-6586-4B71-BFF6-CA81F5893B7FQ35112440-02DCFCC2-58AD-4DB9-B417-1392332CDAADQ35112449-5E0E1002-7E4C-4646-B5C7-20534E66D8ACQ35642571-067593EE-DB8F-4C0B-8F34-95F88D790430Q35677000-784D24CC-15E6-4C30-AF20-574C475D7225Q35915643-6D5E340A-FB3C-4FC7-8EDA-68C5A552CFE8Q36321633-535AE1FF-5518-490D-BE27-A9622E8A6E38Q36369011-92D2D44C-7943-4731-A34D-4D230DB9D413Q36661844-1E29D641-A89D-493D-A94E-90B263D2F01CQ36810282-D4636313-3E34-43F8-809F-A2D765B404B6Q36863077-442EF5C7-29FC-4FA2-8FE6-5EBB86DC8962Q36945725-E259C92E-6B51-4285-A779-00B4B830544DQ37008132-DB7625C1-B799-43E7-A7E0-743B9E730971Q37122401-51858DBC-B458-41FD-8E2C-327E633C2F3FQ37303186-8BAA38ED-372F-44EC-AD7E-2B61C7398700Q37578173-B14F11ED-630A-4D2A-969E-1F89BF43A6BFQ37912258-D9C055EA-9E51-4156-AF62-D40CB28AB7BBQ38013763-F58DE97D-1C04-4627-9FEF-F124FED08F9DQ38127745-29B05A83-E369-4EDC-8726-ED5BC6038EAAQ38188652-F695B250-7913-4A23-B510-59083CBCAE5DQ38210808-9DB0A74D-6E68-4858-9532-3823AB856313Q38222571-D5BA22C2-630A-4761-9687-B18EBCBEC794Q38222575-2BD2BC3D-9F4B-4B07-B53C-66AB80428B75Q38351067-CC70C611-B1B7-46C5-A476-D08A2E5ABC30Q38390937-3AD0BB65-07C6-4A52-837D-059C54D944D4Q38418489-0DA7AA66-00F0-4652-8C81-A13E73C61264Q38590269-5BB431DF-3548-45A8-AAC0-130D880A77EFQ38610808-EE58A395-6926-446C-AFA6-AE5969762EB7Q38885402-30ACAB46-2980-4FAC-9074-B7B362A13D62Q38955500-84A5FEDC-2A03-4924-A60A-4ADB1BA43A6EQ39807578-479C779D-D96C-42F7-B3C0-11EE8978AD2FQ40013630-A86381F9-DBC2-46DB-9668-8F74C7489380Q40261649-48B617E4-0E6F-4739-A2C3-851F813758A9Q41432599-D060369B-A3EE-4812-BB4E-78BC14F82ADFQ41483187-3ABFD44F-3951-48E7-9B98-5F38AB3A58BA
P2860
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Quality-of-life differences be ...... European haemophilia patients.
@en
type
label
Quality-of-life differences be ...... European haemophilia patients.
@en
prefLabel
Quality-of-life differences be ...... European haemophilia patients.
@en
P2093
P2860
P1433
P1476
Quality-of-life differences be ...... European haemophilia patients.
@en
P2093
A Gringeri
E Berntorp
European haemophilia economics study group
P Giangrande
P2860
P356
10.1046/J.1365-2516.2002.00581.X
P577
2002-01-01T00:00:00Z